Ignite Creation Date:
2025-12-24 @ 4:59 PM
Ignite Modification Date:
2026-02-20 @ 11:49 PM
Study NCT ID:
NCT05624450
Status:
RECRUITING
Last Update Posted:
2025-11-17
First Post:
2022-11-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
Sponsor:
AstraZeneca
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Viral Lung Infection and Acute Respiratory Failure | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Acute Respiratory Failure | View |
| None | Acute Respiratory Distress Syndrome | View |
| None | Viral lung infection | View |
| None | Tozorakimab | View |
| None | Supplemental Oxygen | View |
| None | IL-33 | View |
| None | COVID-19 | View |
| None | SARS-CoV-2 | View |
| None | Coronavirus Infections | View |
| None | Virus Diseases | View |
| None | SARS Coronavirus | View |
| None | MEDI3506 | View |
| None | Respiratory Tract Infections | View |
| None | Infections | View |
| None | Lung Diseases | View |
| None | Influenza | View |